$STSS
Sharps Technology Inc. Stock $stss

$stss Overview Financials Valuation SEC Filings Company Website

2022 Q3 Form 10-Q Financial Statement

#000149315222022897 Filed on August 15, 2022

Income Statement

Concept	2022 Q3	2022 Q2	2022 Q1
Revenue			$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$1.339M	$2.231M	$830.9K
YoY Change	35.93%	331.67%	85.65%
% of Gross Profit
Research & Development	$457.6K	$556.9K	$506.4K
YoY Change	28.59%	48.3%	8.3%
% of Gross Profit
Depreciation & Amortization	$127.1K	$83.05K	$73.05K
YoY Change	4695.85%	2272.86%
% of Gross Profit
Operating Expenses	$1.797M	$2.788M	$1.337M
YoY Change	33.98%	243.78%	46.13%
Operating Profit	-$1.797M	-$2.788M	-$1.337M
YoY Change	33.98%	243.78%
Interest Expense	$19.34K	-$1.101M	-$245.4K
YoY Change	64366.67%	-458645.83%	-54642.22%
% of Operating Profit
Other Income/Expense, Net	-$601.0K	$3.265M	-$287.0K
YoY Change	-1821457.58%	1360492.92%
Pretax Income	-$2.398M	$477.8K	-$1.870M
YoY Change	78.8%	-158.93%	104.41%
Income Tax
% Of Pretax Income
Net Earnings	-$2.398M	$477.8K	-$1.870M
YoY Change	78.8%	-158.93%	104.41%
Net Earnings / Revenue
Basic Earnings Per Share	-$0.26	$0.06	-$0.36
Diluted Earnings Per Share	-$260.5K	$55.11K	-$203.8K
COMMON SHARES
Basic Shares Outstanding	9.207M shares	8.669M shares	5.187M shares
Diluted Shares Outstanding	9.207M shares	8.669M shares

Balance Sheet

Concept	2022 Q3	2022 Q2	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$6.390M	$7.808M	$255.6K
YoY Change	2458.9%	1528.88%
Cash & Equivalents	$6.390M	$7.808M	$255.6K
Short-Term Investments
Other Short-Term Assets	$76.44K	$35.54K	$7.000K
YoY Change	-35.21%	-28.92%
Inventory	$233.7K	$127.4K	$122.0K
Prepaid Expenses		$35.54K
Receivables
Other Receivables
Total Short-Term Assets	$6.700M	$7.971M	$384.6K
YoY Change	1722.14%	1405.81%
LONG-TERM ASSETS
Property, Plant & Equipment	$6.644M	$4.181M	$3.940M
YoY Change	474.16%	23428.98%
Goodwill
YoY Change
Intangibles	$55.43K
YoY Change
Long-Term Investments
YoY Change
Other Assets	$188.7K	$2.874M	$610.8K
YoY Change	-91.35%	18.31%
Total Long-Term Assets	$6.833M	$7.055M	$4.551M
YoY Change	104.65%	188.32%
TOTAL ASSETS
Total Short-Term Assets	$6.700M	$7.971M	$384.6K
Total Long-Term Assets	$6.833M	$7.055M	$4.551M
Total Assets	$13.53M	$15.03M	$4.935M
YoY Change	265.1%	404.87%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$712.3K	$558.3K	$852.4K
YoY Change	121.21%	378.2%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$906.4K
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$3.813M	$3.024M	$3.308M
YoY Change	1084.31%	2490.25%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$0.00	$0.00	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$3.813M	$3.024M	$3.308M
Total Long-Term Liabilities	$0.00	$0.00	$0.00
Total Liabilities	$3.813M	$3.024M	$3.308M
YoY Change	1084.31%	2490.25%
SHAREHOLDERS EQUITY
Retained Earnings	-$14.46M	-$12.06M
YoY Change
Common Stock	$922.00	$922.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$9.720M	$12.00M	$1.627M
YoY Change
Total Liabilities & Shareholders Equity	$13.53M	$15.03M	$4.935M
YoY Change	265.1%	404.87%

Cashflow Statement

Concept	2022 Q3	2022 Q2	2022 Q1
OPERATING ACTIVITIES
Net Income	-$2.398M	$477.8K	-$1.870M
YoY Change	78.8%	-158.93%	104.41%
Depreciation, Depletion And Amortization	$127.1K	$83.05K	$73.05K
YoY Change	4695.85%	2272.86%
Cash From Operating Activities	-$1.298M	-$1.877M	-$1.216M
YoY Change	139.19%	169.59%	69.82%
INVESTING ACTIVITIES
Capital Expenditures	-$116.3K	-$463.4K
YoY Change	-73.16%	-25.65%
Acquisitions
YoY Change
Other Investing Activities	-$15.58K	-$2.310M	-$40.00K
YoY Change		22414.62%	-46.67%
Cash From Investing Activities	-$131.9K	-$2.773M	-$40.00K
YoY Change	-69.57%	337.78%	-95.68%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	0.000	12.20M	32.50K
YoY Change	-100.0%	3386.57%	-97.52%
NET CHANGE
Cash From Operating Activities	-1.298M	-1.877M	-1.216M
Cash From Investing Activities	-131.9K	-2.773M	-40.00K
Cash From Financing Activities	0.000	12.20M	32.50K
Net Change In Cash	-1.430M	7.553M	-1.224M
YoY Change	522.6%	-870.85%	269.57%
FREE CASH FLOW
Cash From Operating Activities	-$1.298M	-$1.877M	-$1.216M
Capital Expenditures	-$116.3K	-$463.4K
Free Cash Flow	-$1.182M	-$1.414M	-$1.216M
YoY Change	982.44%	1836.31%	-1007.97%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q2	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2022Q2	STSS	Common Stock Subscription Receivable CommonStockSubscriptionReceivable		usd
	dei	Entity Central Index Key EntityCentralIndexKey	0001737995
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022Q2	us-gaap	Notes Payable Current NotesPayableCurrent		usd
CY2022Q2	STSS	Contingent Stock Liability ContingentStockLiability		usd
CY2021Q2	STSS	Fair Market Value Adjustment For Contingent Stock And Warrants FairMarketValueAdjustmentForContingentStockAndWarrants		usd
	STSS	Fair Market Value Adjustment For Contingent Stock And Warrants FairMarketValueAdjustmentForContingentStockAndWarrants		usd
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims		usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium		usd
	STSS	Adjustment For Contingent Stock AdjustmentForContingentStock		usd
	STSS	Adjustment For Warrants AdjustmentForWarrants		usd
	STSS	Ipo Issuance Costs Relating To Warrants IpoIssuanceCostsRelatingToWarrants		usd
	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther		usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories		usd
	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering		usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable		usd
	us-gaap	Interest Paid Net InterestPaidNet		usd
	STSS	Fmv For Common Stock Issued For Contingent Shares FmvForCommonStockIssuedForContingentShares		usd
	STSS	Vested Stock Options Issued As Consideration For Acquisition VestedStockOptionsIssuedAsConsiderationForAcquisition		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-06-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-41355
	dei	Entity Registrant Name EntityRegistrantName	Sharps Technology, Inc.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	82-3751728
	dei	Entity Address Address Line1 EntityAddressAddressLine1	105 Maxess Road
	dei	Entity Address City Or Town EntityAddressCityOrTown	Melville
	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	11747
	dei	City Area Code CityAreaCode	(631
	dei	Local Phone Number LocalPhoneNumber	574 -4436
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	false
CY2022Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	9207415	shares
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	7808181	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1479166	usd
CY2022Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	35537	usd
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	7995	usd
CY2022Q2	us-gaap	Inventory Net InventoryNet	127441	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	121994	usd
CY2022Q2	us-gaap	Assets Current AssetsCurrent	7971159	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	1609155	usd
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4181099	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3763332	usd
CY2022Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2873864	usd
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	529863	usd
CY2022Q2	us-gaap	Assets Assets	15026122	usd
CY2021Q4	us-gaap	Assets Assets	5902350	usd
CY2022Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	558298	usd
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	804138	usd
CY2021Q4	us-gaap	Notes Payable Current NotesPayableCurrent	700015	usd
CY2021Q4	STSS	Contingent Stock Liability ContingentStockLiability	677000	usd
CY2022Q2	STSS	Warrant Liability WarrantLiability	2465820	usd
CY2021Q4	STSS	Warrant Liability WarrantLiability	585000	usd
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	3024118	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2766153	usd
CY2022Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2022Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	1	shares
CY2022Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	1	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	1	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	1	shares
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	9207415	shares
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	9207415	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	5187062	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	5187062	shares
CY2022Q2	us-gaap	Common Stock Value CommonStockValue	922	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	519	usd
CY2021Q4	STSS	Common Stock Subscription Receivable CommonStockSubscriptionReceivable	-32500	usd
CY2022Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	24060753	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	13835882	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-12059671	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-10667704	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	12002004	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	3136197	usd
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	15026122	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	5902350	usd
CY2022Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	556868	usd
CY2021Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	375511	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1063243	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	843075	usd
CY2022Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2230801	usd
CY2021Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	435376	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3061710	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	883953	usd
CY2022Q2	us-gaap	Operating Expenses OperatingExpenses	2787669	usd
CY2021Q2	us-gaap	Operating Expenses OperatingExpenses	810887	usd
	us-gaap	Operating Expenses OperatingExpenses	4124953	usd
	us-gaap	Operating Expenses OperatingExpenses	1726028	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-2787669	usd
CY2021Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-810887	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-4124953	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1726028	usd
CY2022Q2	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-1100507	usd
CY2021Q2	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	240	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-1345944	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	692	usd
CY2022Q2	STSS	Fair Market Value Adjustment For Contingent Stock And Warrants FairMarketValueAdjustmentForContingentStockAndWarrants	-4365930	usd
	STSS	Fair Market Value Adjustment For Contingent Stock And Warrants FairMarketValueAdjustmentForContingentStockAndWarrants	-4078930	usd
CY2022Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	3265423	usd
CY2021Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	240	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	2732986	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	692	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	477754	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-810647	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1391967	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1725336	usd
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.06
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.17
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.20
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.37
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	8669372	shares
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4827000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6928217	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4712000	shares
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	2130823	usd
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-914689	usd
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	189237	usd
CY2021Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	100000	usd
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	1505371	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-810647	usd
CY2021Q2	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	104766	usd
CY2021Q2	STSS	Stock Issued During Period Issuance Of Common Stock From Subscriptions Value StockIssuedDuringPeriodIssuanceOfCommonStockFromSubscriptionsValue	1660000	usd
CY2021Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	400000	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	2859490	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	3136197	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	3136197	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-1869721	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	328460	usd
CY2022Q1	STSS	Stock Issued During Period Collections Of Common Stock Subscriptions Value StockIssuedDuringPeriodCollectionsOfCommonStockSubscriptionsValue	32500	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	1627436	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	477754	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	477754	usd
CY2022Q2	STSS	Stock Issued During Period Value Initial Public Offering StockIssuedDuringPeriodValueInitialPublicOffering	8974657	usd
CY2022Q2	STSS	Stock Issued During Period Value Contingent Stock Liability StockIssuedDuringPeriodValueContingentStockLiability	496000	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	365606	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	60551	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	12002004	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	12002004	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1391967	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1725336	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	156100	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	3500	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	589553	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	294003	usd
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	60551	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	1299985	usd
	STSS	Adjustment For Contingent Stock AdjustmentForContingentStock	-181000	usd
	STSS	Adjustment For Warrants AdjustmentForWarrants	-3897930	usd
	STSS	Ipo Issuance Costs Relating To Warrants IpoIssuanceCostsRelatingToWarrants	550433	usd
	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	27542	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	5448	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-245840	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	15501	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3093105	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1412332	usd
	us-gaap	Payments To Acquire Machinery And Equipment PaymentsToAcquireMachineryAndEquipment	463355	usd
	us-gaap	Payments To Acquire Machinery And Equipment PaymentsToAcquireMachineryAndEquipment	1473250	usd
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	2350000	usd
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	85262	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2813355	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1558512	usd
	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	14202975	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	2000000	usd
	STSS	Proceeds From Common Stock Subscriptions And Subscriptions Receivable ProceedsFromCommonStockSubscriptionsAndSubscriptionsReceivable	32500	usd
	STSS	Proceeds From Common Stock Subscriptions And Subscriptions Receivable ProceedsFromCommonStockSubscriptionsAndSubscriptionsReceivable	1660000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	12235475	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1660000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	6329015	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1310844	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1479166	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1790203	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	7808181	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	479359	usd
	us-gaap	Interest Paid Net InterestPaidNet	47111	usd
	STSS	Fmv For Common Stock Issued For Contingent Shares FmvForCommonStockIssuedForContingentShares	496000	usd
	STSS	Vested Stock Options And Common Stock For Fixed Assets Acquired VestedStockOptionsAndCommonStockForFixedAssetsAcquired	63612	usd
	STSS	Vested Stock Options And Common Stock For Fixed Assets Acquired VestedStockOptionsAndCommonStockForFixedAssetsAcquired	500000	usd
	STSS	Vested Stock Options Issued As Consideration For Acquisition VestedStockOptionsIssuedAsConsiderationForAcquisition	40901	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84C_eus-gaap--UseOfEstimates_zKApCJLe0Rzb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86E_zRRrgDfkSiv3">Use of Estimates</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. The accounting estimates and assumptions that require management’s most significant, difficult, and subjective judgment include the valuation and recognition of stock-based compensation expense, contingent stock liability, contingent warrant liability, inventory obsolescence provision, depreciation of fixed assets and deferred tax asset valuation. Actual results experienced by the Company may differ from management’s estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0	usd
	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0277	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2022Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	4369233	usd
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	3795366	usd
CY2022Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	188134	usd
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	32034	usd
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4181099	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3763332	usd
	us-gaap	Depreciation Depreciation	156100	usd
	us-gaap	Depreciation Depreciation	3500	usd
	STSS	Remaining Payments Due On Machinery RemainingPaymentsDueOnMachinery	100000	usd
CY2022Q2	STSS	Other Asset Acquisition OtherAssetAcquisition	2873494	usd
CY2021Q4	STSS	Other Asset Acquisition OtherAssetAcquisition	472701	usd
CY2022Q2	STSS	Other Non Current OtherNonCurrent	370	usd
CY2021Q4	STSS	Other Non Current OtherNonCurrent	57162	usd
CY2022Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2873864	usd
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	529863	usd
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	2350000	usd
CY2022Q2	us-gaap	Escrow Deposit EscrowDeposit	2500000	usd
CY2022Q2	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	2000000	usd
CY2017Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	20000000	shares
CY2017Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2019Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2019Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000	shares
CY2019Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q1	us-gaap	Conversion Of Stock Description ConversionOfStockDescription	Pursuant to the merger agreement, (i) the Company merged with and into Sharps Nevada, (ii) each 3.5 shares of common stock of the Company were converted into one share of common stock of Sharps Nevada and (iii) the articles of incorporation and bylaws of Sharps Nevada, became the articles of incorporation and bylaws of the surviving corporation
CY2022Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2022Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2022Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000	shares
CY2022Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2022Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
	us-gaap	Stock Issued During Period Shares Issued For Services StockIssuedDuringPeriodSharesIssuedForServices	35000	shares
	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	60551	usd
	us-gaap	Payments For Repurchase Of Initial Public Offering PaymentsForRepurchaseOfInitialPublicOffering	2401338	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	5.32
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	228655	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate	0.9347	pure
CY2022Q2	STSS	Warrant Liability WarrantLiability	2465820	usd
CY2022Q2	STSS	Fair Market Value Of Note Warrants FairMarketValueOfNoteWarrants	157647	usd
CY2022Q2	STSS	Fair Market Value Of Trading And Overall Warrants FairMarketValueOfTradingAndOverallWarrants	5778750	usd
CY2022Q2	STSS	Fair Market Value Of Change In Fair Value Of Warrant Liability FairMarketValueOfChangeInFairValueOfWarrantLiability	-3470577	usd
CY2022Q2	STSS	Warrant Liability WarrantLiability	2465820	usd
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1137479	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	5.18
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	267500	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.21
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1404979	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	4.42
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	1070910	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	4.55
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	267500	shares
CY2022Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	781386	usd
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P29M
CY2022Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	365606	usd
CY2021Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	104766	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	589553	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	293983	usd
CY2022Q2	us-gaap	Effective Income Tax Rate Reconciliation Disposition Of Business EffectiveIncomeTaxRateReconciliationDispositionOfBusiness	0	pure
	us-gaap	Effective Income Tax Rate Reconciliation Disposition Of Business EffectiveIncomeTaxRateReconciliationDispositionOfBusiness	0	pure
CY2021Q2	us-gaap	Effective Income Tax Rate Reconciliation Disposition Of Business EffectiveIncomeTaxRateReconciliationDispositionOfBusiness	0	pure
	us-gaap	Effective Income Tax Rate Reconciliation Disposition Of Business EffectiveIncomeTaxRateReconciliationDispositionOfBusiness	0	pure
CY2022Q2	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	7808181	usd
CY2022Q2	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	7808181	usd
CY2022Q2	STSS	Warrant Liability WarrantLiability	2465820	usd
CY2022Q2	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	2465820	usd

Files In Submission

Name	View Source	Status
0001493152-22-022897-index-headers.html	Edgar Link	pending
0001493152-22-022897-index.html	Edgar Link	pending
0001493152-22-022897.txt	Edgar Link	pending
0001493152-22-022897-xbrl.zip	Edgar Link	pending
ex10-1.htm	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
from10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
from10-q_htm.xml	Edgar Link	completed
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
stss-20220630.xsd	Edgar Link	pending
stss-20220630_def.xml	Edgar Link	unprocessable
stss-20220630_lab.xml	Edgar Link	unprocessable
stss-20220630_pre.xml	Edgar Link	unprocessable
stss-20220630_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$STSS
Sharps Technology Inc. Stock $stss

2022 Q3 Form 10-Q Financial Statement

#000149315222022897 Filed on August 15, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$STSS Sharps Technology Inc. Stock $stss

2022 Q3 Form 10-Q Financial Statement

#000149315222022897 Filed on August 15, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$STSS
Sharps Technology Inc. Stock $stss